|
ZNF333 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.30190311256706E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.71149818948425E-11 |
| Normal-vs-Stage2 |
4.0405999657267E-09 |
| Normal-vs-Stage3 |
9.09794461989577E-12 |
| Normal-vs-Stage4 |
3.93609589366406E-11 |
| Stage1-vs-Stage2 |
9.945800E-01 |
| Stage1-vs-Stage3 |
1.294810E-01 |
| Stage1-vs-Stage4 |
1.017640E-01 |
| Stage2-vs-Stage3 |
3.181400E-01 |
| Stage2-vs-Stage4 |
2.506000E-01 |
| Stage3-vs-Stage4 |
7.850200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.21065437861535E-12 |
| Normal-vs-AfricanAmerican |
1.54633999999154E-05 |
| Normal-vs-Asian |
4.4636999985137E-08 |
| Caucasian-vs-AfricanAmerican |
4.894200E-01 |
| Caucasian-vs-Asian |
6.440100E-02 |
| AfricanAmerican-vs-Asian |
5.594000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.23160412160928E-11 |
| Normal-vs-Female |
2.36149988452894E-11 |
| Male-vs-Female |
9.588400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.18939968984932E-10 |
| Normal-vs-Age(41-60Yrs) |
3.83939546821921E-11 |
| Normal-vs-Age(61-80Yrs) |
2.367994689223E-11 |
| Normal-vs-Age(81-100Yrs) |
3.844600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.285200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.466000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.337800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.092000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.320000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.288800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.34539999977024E-07 |
| Classical-VS-Follicular |
6.701000E-01 |
| Classical-VS-Other |
8.173800E-01 |
| Classical-VS-Normal |
4.43590053578191E-10 |
| Tall-VS-Follicular |
4.08210000002462E-06 |
| Tall-VS-Other |
1.708840E-01 |
| Tall-VS-Normal |
3.5527136788005E-15 |
| Follicular-VS-Other |
7.426600E-01 |
| Follicular-VS-Normal |
6.00689997742876E-09 |
| Other-VS-Normal |
4.819500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.53039844422665E-11 |
| Normal-vs-N1 |
2.0785000387491E-09 |
| N0-vs-N1 |
8.701600E-01 |
|
|
